ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) Stock Price, Forecast & Analysis

OSL:AZT • NO0010014632

24 NOK
+1 (+4.35%)
Last: Feb 27, 2026, 07:00 PM

AZT.OL Key Statistics, Chart & Performance

Key Statistics
Market Cap1.23B
Revenue(TTM)N/A
Net Income(TTM)7.66M
Shares51.07M
Float43.58M
52 Week High31.4
52 Week Low14
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)0.19
PE126.32
Fwd PE52.23
Earnings (Next)05-07
IPO2005-11-04
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
AZT.OL short term performance overview.The bars show the price performance of AZT.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 -10 -15

AZT.OL long term performance overview.The bars show the price performance of AZT.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20

The current stock price of AZT.OL is 24 NOK. In the past month the price increased by 10.09%. In the past year, price increased by 30.72%.

ARCTICZYMES TECHNOLOGIES ASA / AZT Daily stock chart

AZT.OL Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to AZT.OL. When comparing the yearly performance of all stocks, AZT.OL turns out to be only a medium performer in the overall market: it outperformed 67.23% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
AZT.OL Full Technical Analysis Report

AZT.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to AZT.OL. AZT.OL has an excellent financial health rating, but there are some minor concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
AZT.OL Full Fundamental Analysis Report

AZT.OL Financial Highlights

Over the last trailing twelve months AZT.OL reported a non-GAAP Earnings per Share(EPS) of 0.19. The EPS increased by 35.71% compared to the year before.


Industry RankSector Rank
PM (TTM) 7.43%
ROA 2.17%
ROE 2.32%
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%116.67%
Sales Q2Q%31.1%
EPS 1Y (TTM)35.71%
Revenue 1Y (TTM)N/A
AZT.OL financials

AZT.OL Forecast & Estimates

6 analysts have analysed AZT.OL and the average price target is 33.66 NOK. This implies a price increase of 40.25% is expected in the next year compared to the current price of 24.

For the next year, analysts expect an EPS growth of 141.87% and a revenue growth 26.73% for AZT.OL


Analysts
Analysts80
Price Target33.66 (40.25%)
EPS Next Y141.87%
Revenue Next Year26.73%
AZT.OL Analyst EstimatesAZT.OL Analyst Ratings

AZT.OL Ownership

Ownership
Inst Owners15.37%
Ins Owners0.33%
Short Float %N/A
Short RatioN/A
AZT.OL Ownership

About AZT.OL

Company Profile

AZT logo image ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.

Company Info

ARCTICZYMES TECHNOLOGIES ASA

Sykehusveien 23

Tromso TROMS NO

Employees: 53

AZT Company Website

AZT Investor Relations

Phone: 4777648900

ARCTICZYMES TECHNOLOGIES ASA / AZT.OL FAQ

What does AZT do?

ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.


What is the stock price of ARCTICZYMES TECHNOLOGIES ASA today?

The current stock price of AZT.OL is 24 NOK. The price increased by 4.35% in the last trading session.


What is the dividend status of ARCTICZYMES TECHNOLOGIES ASA?

AZT.OL does not pay a dividend.


How is the ChartMill rating for ARCTICZYMES TECHNOLOGIES ASA?

AZT.OL has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Can you provide the sector and industry classification for ARCTICZYMES TECHNOLOGIES ASA?

ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) operates in the Health Care sector and the Biotechnology industry.


How is the valuation of ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) based on its PE ratio?

The PE ratio for ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) is 126.32. This is based on the reported non-GAAP earnings per share of 0.19 and the current share price of 24 NOK.